Liabilities / Assets
64th percentile
Tied with the lowest-debt nonprofits in its peer group.
990EZ • Fiscal year 2023 • EIN 45-5240664
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
64th percentile
Tied with the lowest-debt nonprofits in its peer group.
Liabilities / Revenue
63rd percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
98th percentile
Higher net margin than 98% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
78th percentile
Faster asset growth than 78% of similar nonprofits.
Revenue Growth
7th percentile
Faster revenue growth than 7% of similar nonprofits.
Assets
Up$65,016
Up $13,961 (+27%) from 2022
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Flat$0
Flat from 2022
Revenue
Down$14,819
Down $23,800 (-62%) from 2022
Expenses
Down$769
Down $1,576 (-67%) from 2022
Net Income
Down$14,050
Down $22,224 (-61%) from 2022
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
ReducetheincidenceandimprovetheoutcomeofHepatobiliarycancersbypromotingresearchtoidentifythediagnosticbiomarkersandtherapeutictargetsinthiscomplexandheterogeneousgroupofdiseases.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2023 • Form 990EZSummary only. Only limited summary data is available for this year.